GALT Insider Trading

Insider Ownership Percentage: 52.70%
Insider Buying (Last 12 Months): $18,115.42
Insider Selling (Last 12 Months): $65,248.38

Galectin Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Galectin Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Galectin Therapeutics Share Price & Price History

Current Price: $2.50
Price Change: Price Decrease of -0.12 (-4.58%)
As of 06/17/2024 05:19 PM ET

This chart shows the closing price history over time for GALT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Galectin Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2024Richard A. Zordani, Jr.DirectorBuy1,000$3.52$3,520.001,000View SEC Filing Icon  
4/24/2024Joel LewisCEOBuy1,000$3.39$3,390.002,000View SEC Filing Icon  
4/22/2024James C CzirrMajor ShareholderSell21,323$3.06$65,248.385,925,884View SEC Filing Icon  
4/22/2024Kevin D. FreemanDirectorBuy2,500$2.98$7,450.0025,969View SEC Filing Icon  
1/16/2024Kary EldredDirectorBuy500$1.79$895.0049,313View SEC Filing Icon  
7/19/2023Kary EldredDirectorBuy1,598$1.79$2,860.4248,813View SEC Filing Icon  
2/21/2023Kary EldredDirectorBuy1,000$1.59$1,590.0047,215View SEC Filing Icon  
2/16/2023Joel LewisCEOBuy1,000$1.52$1,520.001,000View SEC Filing Icon  
1/25/2023Kary EldredDirectorBuy1,300$1.11$1,443.0046,215View SEC Filing Icon  
11/17/2022Jack W CallicuttCFOBuy4,000$1.32$5,280.007,614View SEC Filing Icon  
10/28/2022Kevin D. FreemanDirectorBuy10,000$1.41$14,100.0075,000View SEC Filing Icon  
7/28/2022Richard A. Zordani, Jr.DirectorBuy5,000$2.50$12,500.0029,583View SEC Filing Icon  
5/19/2022Kevin D. FreemanDirectorBuy5,000$1.33$6,650.0065,000View SEC Filing Icon  
4/18/2022Kevin D. FreemanDirectorBuy5,000$1.71$8,550.0060,000View SEC Filing Icon  
4/4/2022Richard A. Zordani, Jr.DirectorBuy5,000$1.60$8,000.0024,583View SEC Filing Icon  
2/2/2022Fund L.P. 10XMajor ShareholderSell10,000$2.10$21,000.00View SEC Filing Icon  
1/21/2022Elissa J. SchwartzDirectorBuy1,000$2.00$2,000.00View SEC Filing Icon  
1/19/2022Kevin D. FreemanDirectorBuy5,000$1.96$9,800.00View SEC Filing Icon  
1/14/2022Richard A. Zordani, Jr.DirectorBuy5,000$2.02$10,100.00View SEC Filing Icon  
1/11/2022Fund L.P. 10XMajor ShareholderSell10,000$2.10$21,000.00View SEC Filing Icon  
12/6/2021Kevin D. FreemanDirectorBuy5,000$2.34$11,700.00View SEC Filing Icon  
12/2/2021Fund L.P. 10XMajor ShareholderSell10,000$2.37$23,700.00View SEC Filing Icon  
11/1/2021Fund L.P. 10XMajor ShareholderSell10,000$3.19$31,900.00View SEC Filing Icon  
10/29/2021Kevin D. FreemanDirectorBuy2,000$3.17$6,340.00View SEC Filing Icon  
10/21/2021Kevin D. FreemanDirectorBuy2,000$3.19$6,380.00View SEC Filing Icon  
10/19/2021Kevin D. FreemanDirectorBuy3,000$3.37$10,110.00View SEC Filing Icon  
10/15/2021Fund L.P. 10XMajor ShareholderSell10,000$3.37$33,700.00View SEC Filing Icon  
10/4/2021Fund L.P. 10XMajor ShareholderSell10,000$3.62$36,200.00View SEC Filing Icon  
9/23/2021Kevin D. FreemanDirectorBuy3,000$3.88$11,640.00View SEC Filing Icon  
9/1/2021Fund L.P. 10XMajor ShareholderSell10,000$3.91$39,100.00View SEC Filing Icon  
8/2/2021Fund L.P. 10XMajor ShareholderSell10,000$3.25$32,500.00View SEC Filing Icon  
7/9/2021Fund L.P. 10XMajor ShareholderSell10,000$3.54$35,400.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Galectin Therapeutics (NASDAQ:GALT)

11.68% of Galectin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GALT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Galectin Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024Vanguard Group Inc.1,979,891$4.73M0.0%+2.0%3.198%Search for SEC Filing on Google Icon
5/7/2024Wealthspire Advisors LLC398,374$0.95M0.0%+116.7%0.644%Search for SEC Filing on Google Icon
5/4/2024Geneos Wealth Management Inc.408,850$0.98M0.0%-0.9%0.660%Search for SEC Filing on Google Icon
4/19/2024Retirement Guys Formula LLC33,732$81K0.0%+56.9%0.054%Search for SEC Filing on Google Icon
2/6/2024Solutions 4 Wealth Ltd36,085$60K0.2%N/A0.058%Search for SEC Filing on Google Icon
2/2/2024Atria Wealth Solutions Inc.249,800$0.42M0.0%-3.8%0.404%Search for SEC Filing on Google Icon
2/1/2024Cutter & CO Brokerage Inc.117,488$0.20M0.1%-9.3%0.190%Search for SEC Filing on Google Icon
1/22/2024Retirement Guys Formula LLC21,500$36K0.0%+87.0%0.035%Search for SEC Filing on Google Icon
1/9/2024Beacon Capital Management LLC23,905$40K0.0%+89.6%0.039%Search for SEC Filing on Google Icon
11/8/2023D.A. Davidson & CO.37,825$73K0.0%+15.2%0.061%Search for SEC Filing on Google Icon
10/16/2023Traynor Capital Management Inc.34,707$67K0.0%N/A0.056%Search for SEC Filing on Google Icon
10/11/2023AE Wealth Management LLC26,841$52K0.0%+72.7%0.043%Search for SEC Filing on Google Icon
8/3/2023Atria Wealth Solutions Inc.260,800$0.38M0.0%-3.7%0.439%Search for SEC Filing on Google Icon
7/25/2023Summit Trail Advisors LLC20,000$29K0.0%N/A0.034%Search for SEC Filing on Google Icon
7/13/2023Cambridge Investment Research Advisors Inc.134,332$0.19M0.0%-5.7%0.226%Search for SEC Filing on Google Icon
5/12/2023Independent Advisor Alliance36,100$76K0.0%N/A0.061%Search for SEC Filing on Google Icon
5/9/2023Wealthspire Advisors LLC183,862$0.39M0.0%N/A0.309%Search for SEC Filing on Google Icon
5/9/2023Wedbush Securities Inc.15,498$33K0.0%-36.7%0.026%Search for SEC Filing on Google Icon
4/25/2023Geneos Wealth Management Inc.427,400$0.90M0.1%-1.7%0.719%Search for SEC Filing on Google Icon
2/7/2023Commonwealth Equity Services LLC101,522$0.11M0.0%+165.6%0.170%Search for SEC Filing on Google Icon
2/7/2023Benjamin F. Edwards & Company Inc.34,412$39K0.0%+78.7%0.058%Search for SEC Filing on Google Icon
2/3/2023Cutter & CO Brokerage Inc.129,488$0.15M0.0%-23.6%0.217%Search for SEC Filing on Google Icon
1/31/2023Geneos Wealth Management Inc.434,800$0.49M0.0%-2.3%0.729%Search for SEC Filing on Google Icon
11/7/2022D.A. Davidson & CO.32,810$53K0.0%-27.6%0.055%Search for SEC Filing on Google Icon
7/28/2022D.A. Davidson & CO.45,335$59K0.0%-18.0%0.076%Search for SEC Filing on Google Icon
7/19/2022Commonwealth Equity Services LLC38,220$50K0.0%+42.1%0.064%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.1,265,820$2.04M0.0%+1.5%2.133%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC26,902$43K0.0%+59.2%0.045%Search for SEC Filing on Google Icon
5/3/2022Cutter & CO Brokerage Inc.169,578$0.27M0.1%-7.6%0.286%Search for SEC Filing on Google Icon
2/9/2022Geneos Wealth Management Inc.480,767$1M0.0%-2.2%0.810%Search for SEC Filing on Google Icon
2/7/2022Benjamin F. Edwards & Company Inc.29,615$61K0.0%+25.5%0.050%Search for SEC Filing on Google Icon
2/7/2022Ameritas Advisory Services LLC44,232$92K0.0%N/A0.075%Search for SEC Filing on Google Icon
2/3/2022Cambridge Investment Research Advisors Inc.153,027$0.32M0.0%-7.0%0.258%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.1,247,401$2.58M0.0%-2.1%2.102%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC39,191$0.15M0.0%-30.2%0.066%Search for SEC Filing on Google Icon
11/15/2021Capstone Investment Advisors LLC42,260$0.16M0.0%N/A0.071%Search for SEC Filing on Google Icon
11/12/2021Ameritas Investment Company LLC44,232$0.17M0.0%+12.7%0.075%Search for SEC Filing on Google Icon
11/12/2021Centaurus Financial Inc.22,614$88K0.0%+44.8%0.038%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC540,866$2.10M0.0%+32.2%0.912%Search for SEC Filing on Google Icon
11/10/2021Buckingham Strategic Wealth LLC10,734$42K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.787,582$3.06M0.0%-0.8%1.328%Search for SEC Filing on Google Icon
11/8/2021Keybank National Association OH100,000$0.39M0.0%N/A0.169%Search for SEC Filing on Google Icon
11/4/2021QCI Asset Management Inc. NY55,000$0.21M0.0%+120.0%0.093%Search for SEC Filing on Google Icon
11/2/2021Raymond James & Associates13,096$51K0.0%N/A0.022%Search for SEC Filing on Google Icon
11/2/2021Benjamin F. Edwards & Company Inc.23,600$92K0.0%-32.0%0.040%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.164,498$0.64M0.0%-2.3%0.277%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC11,902$46K0.0%N/A0.020%Search for SEC Filing on Google Icon
10/8/2021Wedbush Securities Inc.30,998$0.12M0.0%+72.2%0.052%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC56,047$0.18M0.0%+62.9%0.096%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP47,509$0.15M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC568,690$1.82M0.0%N/A0.979%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC10,965$35K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC56,128$0.18M0.0%N/A0.097%Search for SEC Filing on Google Icon
8/16/2021Ameritas Investment Company LLC39,232$0.13M0.0%N/A0.068%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP19,285$62K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.17,413$56K0.0%-77.5%0.030%Search for SEC Filing on Google Icon
8/16/2021State Street Corp158,759$0.51M0.0%-74.2%0.273%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd98,700$0.32M0.1%N/A0.170%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP47,509$0.15M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC370,199$1.19M0.0%+20.6%0.637%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp96,270$0.31M0.0%-77.1%0.166%Search for SEC Filing on Google Icon
8/13/2021LPL Financial LLC52,034$0.17M0.0%+219.5%0.090%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC409,013$1.31M0.0%-36.7%0.704%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,953,419$6.25M0.0%+1.1%3.362%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd12,419$40K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC139,181$0.45M0.0%N/A0.240%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp23,080$74K0.0%-76.9%0.040%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.793,934$2.54M0.0%-69.7%1.367%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC15,600$50K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/10/2021Cambridge Investment Research Advisors Inc.168,316$0.54M0.0%N/A0.290%Search for SEC Filing on Google Icon
8/10/2021Rockefeller Capital Management L.P.10,386$33K0.0%+419.3%0.018%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.1,273,157$4.07M0.0%+4.2%2.192%Search for SEC Filing on Google Icon
6/17/2021Geneos Wealth Management Inc.511,606$2.26M0.1%+5.4%0.881%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC14,683$32K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.45,775$99K0.0%-10.8%0.080%Search for SEC Filing on Google Icon
5/17/2021Vivaldi Capital Management LLC10,668$45K0.0%-30.9%0.019%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC177,035$0.38M0.0%-4.2%0.310%Search for SEC Filing on Google Icon
5/14/2021Occudo Quantitative Strategies LP18,967$41K0.0%N/A0.033%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP11,977$26K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC31,094$68K0.0%+159.0%0.054%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC307,000$0.67M0.0%+1,864.5%0.537%Search for SEC Filing on Google Icon
5/13/2021Neuberger Berman Group LLC13,614$30K0.0%-25.2%0.024%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp99,901$0.22M0.0%-7.0%0.175%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can21,329$53K0.0%+272.7%0.037%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp421,103$0.91M0.0%-7.0%0.737%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC645,867$1.40M0.0%+0.6%1.130%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.100,555$0.22M0.0%-3.0%0.176%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.2,620,626$5.69M0.0%+0.9%4.585%Search for SEC Filing on Google Icon
5/7/2021D.A. Davidson & CO.65,310$0.14M0.0%-91.5%0.114%Search for SEC Filing on Google Icon
4/26/2021Wedbush Securities Inc.17,998$39K0.0%-12.2%0.031%Search for SEC Filing on Google Icon
3/2/2021FormulaFolio Investments LLC12,710$28K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.103,713$0.23M0.0%+378.5%0.182%Search for SEC Filing on Google Icon
2/12/2021Raymond James Financial Services Advisors Inc.18,229$41K0.0%N/A0.032%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp452,957$1.01M0.0%-2.8%0.794%Search for SEC Filing on Google Icon
2/11/2021Barclays PLC12,006$27K0.0%-30.5%0.021%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC15,627$35K0.0%N/A0.027%Search for SEC Filing on Google Icon
2/10/2021D.A. Davidson & CO.767,321$1.72M0.0%-10.1%1.344%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN96,815$0.22M0.0%+69.1%0.170%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.2,598,089$5.82M0.0%+3.8%4.552%Search for SEC Filing on Google Icon
2/4/2021Cambridge Investment Research Advisors Inc.179,556$0.40M0.0%-6.1%0.315%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Galectin Therapeutics logo
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, that is in Phase 2b/3 clinical trial, to prevent esophageal varices in patient with non-alcoholic steatohepatitis (NASH) cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Read More on Galectin Therapeutics

Today's Range

Now: $2.50
Low: $2.50
High: $2.66

50 Day Range

MA: $3.19
Low: $2.60
High: $4.20

52 Week Range

Now: $2.50
Low: $1.28
High: $4.27

Volume

125,239 shs

Average Volume

134,697 shs

Market Capitalization

$155.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65

Who are the company insiders with the largest holdings of Galectin Therapeutics?

Galectin Therapeutics' top insider investors include:
  1. James C Czirr (Major Shareholder)
  2. Kevin D Freeman (Director)
  3. Kary Eldred (Director)
  4. Richard A Jr Zordani (Director)
  5. Jack W Callicutt (CFO)
  6. Joel Lewis (CEO)
Learn More about top insider investors at Galectin Therapeutics.

Who are the major institutional investors of Galectin Therapeutics?

Galectin Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 3.20%
  2. Geneos Wealth Management Inc. — 0.66%
  3. Wealthspire Advisors LLC — 0.64%
  4. Retirement Guys Formula LLC — 0.05%
Learn More about top institutional investors of Galectin Therapeutics stock.

Which major investors are selling Galectin Therapeutics stock?

In the last quarter, GALT stock was sold by these institutional investors:
  1. Geneos Wealth Management Inc.

Which major investors are buying Galectin Therapeutics stock?

In the last quarter, GALT stock was purchased by institutional investors including:
  1. Wealthspire Advisors LLC
  2. Vanguard Group Inc.
  3. Retirement Guys Formula LLC
In the last year, these company insiders have bought Galectin Therapeutics stock:
  1. James C Czirr (Major Shareholder)
  2. Kevin D Freeman (Director)
  3. Kary Eldred (Director)
  4. Richard A Jr Zordani (Director)
  5. Jack W Callicutt (CFO)
Learn More investors buying Galectin Therapeutics stock.